Meeting Banner
Abstract #0039

A New Biomarker for the Assessment of Early Tumor Response to Chemotherapy Using MR Elastography (MRE)

SUMMA25Kay Pelletier1, Kiaran McGee2, Jun Chen2, Kevin Glaser2, Stephen Ansell3, Richard Ehman2

1Mayo Graduate School, Mayo Clinic, Rochester, MN, United States; 2Radiology, Mayo Clinic, Rochester, MN, United States; 3Hematology, Mayo Clinic, Rochester, MN, United States

 

Keywords

additional administration agents allow allowed alone alteration alternatively anal animal appreciated approval assessment asterisk bandpass become becomes blue body breathe caliper cancer capable care cells chemotherapeutic chemotherapy circle clinic clinically coil committee complications confirm considered contiguous control cycles days decreased delay detecting determine developed dial diameter direct driver drug early effective effectiveness efficacy efforts either encoding essential excluded exists experimental filter flow frequency general generally genetically gradient grow grown hematology heterogeneities hours hypothesis hypothesize identification improve in vivo included individualized induced initial initiation injection inserted institutional involve larger leukemia long mainly maps materials mayo measurably metabolic metric mice minimize model models motion mouse needle nonspecific offsets ongoing option placebo radians radiology receive received reconstructed reduce reduction remained response saline scanner school sensitivity setup shear short side significantly slice slightly square statistically steady stiffness subcutaneous suggested supported tended term therapeutic therapy tissue toxicity transmit treated treatment tumor tumors vacuum vibrations visibly volume volumetric whole